During the past decade, Synexus Clinical Research US, Inc conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 14 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 14 clinical trials were completed. i.e. 56% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "University of Southern California" with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc" #1 collaborator was "Alzheimer's Therapeutic Research Institute" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc" are "Alzheimer Disease" (10 trials), "Diabetic Peripheral Neuropathic Pain" (3 trials), "Osteoarthritis" (3 trials), "Atrial Fibrillation" (2 trials) and "Chronic Low-back Pain" (2 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc" in a lesser frequency.

Most popular intervention types in "Synexus Clinical Research US, Inc" are "Drug" (26 trials), "Biological" (6 trials), "Other" (4 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "LY3556050" (3 trials), "Ad26.COV2.S" (2 trials), "LY3016859" (2 trials) and "LY3372993" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Clinical Research US, Inc" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Synexus Clinical Research US, Inc". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Synexus Clinical Research US, Inc, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Clinical Research US, Inc, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".